In a 76‑year‑old female with a non‑toxic multinodular goitre on carbimazole 5 mg twice daily, suppressed thyroid‑stimulating hormone, low‑normal triiodothyronine, elevated thyroxine, and HbA1c 6.01 % undergoing pre‑operative assessment for orthopedic hip surgery, what endocrine review and peri‑operative management should be documented?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Endocrine Review Documentation

This patient requires immediate optimization of her thyroid status before hip surgery, with carbimazole dose adjustment to achieve euthyroidism, addition of beta-blockade for cardiac protection, and close monitoring for potential thyroid storm risk perioperatively.

Current Clinical Assessment

Thyroid Status Analysis

Your patient presents with biochemical hyperthyroidism despite being on carbimazole 5mg BD:

  • TSH 0.010 mU/L (suppressed)
  • T4 110.1 nmol/L (elevated)
  • T3 2.15 nmol/L (low-normal)

This indicates inadequate control of her toxic multinodular goiter. The diagnosis is non-toxic multinodular goiter that has become autonomous (toxic), which is common in elderly patients with longstanding goiters 1.

Glycemic Status

  • HbA1c 6.01% indicates prediabetes, not requiring insulin therapy but warranting perioperative glucose monitoring 2

Critical Perioperative Concerns

High-Risk Features

This 76-year-old woman has multiple risk factors for perioperative complications:

  • Elderly age with cardiovascular vulnerability
  • Uncontrolled hyperthyroidism (suppressed TSH, elevated T4)
  • Impending major orthopedic surgery with significant physiologic stress
  • Risk of thyroid storm from surgical stress 1

Patients with toxic multinodular goiter who are elderly or have cardiovascular disease should be treated with beta-blockade and rendered euthyroid before elective surgery 1.

Immediate Management Plan

1. Optimize Antithyroid Therapy

  • Increase carbimazole to achieve euthyroidism before surgery
  • Target: TSH normalization and T4 within normal range
  • Monitor thyroid function weekly until controlled 1
  • Check CBC with differential to rule out agranulocytosis (rare but serious complication occurring in first months of therapy) 1, 3
  • Check liver function tests given her age and carbimazole use 1

2. Add Beta-Blockade

Initiate propranolol or metoprolol immediately for:

  • Cardiac protection in elderly patient
  • Control of adrenergic symptoms
  • Prevention of perioperative tachycardia/arrhythmias
  • Continue through surgery and wean postoperatively 1

3. Surgical Timing Decision

Delay elective hip surgery until euthyroid if possible:

  • Ideally TSH >0.1 mU/L and T4 normalized
  • If surgery cannot be delayed and is urgent, proceed with:
    • Adequate beta-blockade
    • Potassium iodide (5-7 drops Lugol's solution TID) for 10 days preoperatively to decrease thyroid vascularity 1
    • Experienced anesthesiologist aware of thyroid storm risk 1

4. Perioperative Monitoring Protocol

  • Continue carbimazole through morning of surgery
  • Maintain beta-blockade perioperatively
  • Monitor for thyroid storm: fever, tachycardia >140, altered mental status, hypotension
  • Capillary glucose monitoring perioperatively given HbA1c 6.01% 2
  • Target blood glucose <10 mmol/L (180 mg/dL) perioperatively

Specific Carbimazole Considerations

Medication Safety

  • Patient education critical: Stop immediately if fever, pharyngitis, or jaundice develop (agranulocytosis warning signs) 1, 3
  • Carbimazole-induced agranulocytosis typically occurs within first 2-3 months of therapy 3
  • Hepatotoxicity risk in elderly patients—monitor LFTs 4

Alternative if Intolerance

If carbimazole causes adverse effects:

  • Do NOT switch to propylthiouracil in serious reactions 1
  • Consider radioactive iodine postoperatively for definitive treatment 1
  • Thyroidectomy is alternative but adds surgical risk 1

Post-Hip Surgery Endocrine Plan

Short-term (First 6 months)

  • Continue carbimazole with monthly thyroid function monitoring
  • Wean beta-blocker once stable and euthyroid 1
  • Monitor for hypothyroidism development

Long-term Definitive Treatment

For elderly patients with toxic multinodular goiter, definitive treatment options include 1:

  1. Radioactive iodine (131I) - preferred in elderly, safe and effective
  2. Thyroidectomy - if large goiter with compression symptoms
  3. Long-term low-dose carbimazole - acceptable in elderly with limited longevity 1

Given her age (76) and surgical risk, radioactive iodine therapy 3-6 months post-hip surgery would be most appropriate for definitive management 1.

Documentation Summary

Diagnosis: Toxic multinodular goiter, inadequately controlled on current carbimazole dose; Prediabetes (HbA1c 6.01%)

Perioperative Risk: High risk for thyroid storm and cardiac complications

Plan:

  1. Increase carbimazole dose, add beta-blockade
  2. Delay surgery until euthyroid if possible
  3. If urgent surgery: potassium iodide pretreatment, continue carbimazole and beta-blocker
  4. Perioperative thyroid storm precautions and glucose monitoring
  5. Definitive radioactive iodine therapy post-recovery

Contraindications to immediate surgery: Uncontrolled hyperthyroidism in elderly patient undergoing major surgery without adequate preparation 1

References

1
Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Related Questions

When should maintenance carbimazole be discontinued in a patient with Graves disease who is euthyroid, with thyroid‑stimulating hormone values <0.01–0.02 up to 0.04 and free T4 approximately 18 pmol/L?
After 4 weeks of carbimazole therapy, the patient's free thyroxine (free T4) is 20 pmol/L; how should the carbimazole dose be adjusted and what follow‑up is recommended?
Should the patient be referred to an endocrinologist for evaluation of bilateral thyromegaly with a persistent stable multinodular goiter?
In a 58‑year‑old woman with multinodular goiter scheduled for surgery who has insomnia, hand tremor, dizziness, a suppressed TSH (~0.1 mIU/L) and normal FT4 (13.3 pmol/L), should antithyroid medication be started, what regimen should be used, and what further management is recommended?
In a patient with a large asymmetrically enlarged right thyroid lobe showing multinodular goiter with substernal/mediastinal extension, mild leftward tracheal shift, an aberrant retro‑esophageal right subclavian artery, and no significant airway narrowing or pathologic lymphadenopathy, what are the appropriate next diagnostic and management steps?
What is the recommended third-line therapy for adult patients with advanced or metastatic gastrointestinal stromal tumor (GIST) after progression on imatinib and sunitinib?
Can hepatitis C infection cause peripheral arthritis with a positive rheumatoid factor and an erythrocyte sedimentation rate of 110 mm/h?
How many days does it take for full recovery from reactive knee arthritis following Mycoplasma pneumoniae infection?
In a patient with no personal or family history of cardiovascular disease but with elevated low‑density lipoprotein cholesterol, is it reasonable for the patient to be hesitant to start statin therapy because of diabetes risk, and what management strategies should be considered?
How should a 76‑year‑old woman with multinodular goitre on carbimazole, suppressed TSH, low‑normal T3 and a total T4 of 110.1 nmol/L (within the assay reference range 66–181 nmol/L) be managed endocrinologically before elective hip surgery?
Which of the following statements about aspirin is false? A) It irreversibly inhibits cyclooxygenase‑1. B) It has a proven benefit when administered to individuals with established cardiovascular disease. C) It increases the risk of gastrointestinal bleeding. D) Its antiplatelet effect lasts 7–10 days. E) Its administration at a dose of 75–100 mg daily is recommended for primary prevention in individuals at moderate cardiovascular risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.